DOBUTREX sol perf 250 mg/50ml flac 50 ml
7680456870230
CH-45687
C01CA07
02.05.2.
1 / 3
google
Details
- Product number
- 4568702
- CPT
- -
- Packaging group
- 50 ml
- Unit
- Durchstechflasche(n)
- Composition
- dobutaminum 250 mg ut dobutamini hydrochloridum, natrii chloridum, acidum hydrochloridum, E 223 3 mg, aqua ad iniectabile ad solutionem pro 50 ml corresp. natrium 153.14 mg.
Articles (1)
Dobutrex 250 mg/50 ml, Infusionslösung / Konzentrat zur Herstellung einer Infusionslösung
Infusionslösung
50 ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
250.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
153.14 MG | Substance | HBESI |
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 45687
- Drug name
- Dobutrex 250 mg/50 ml, Infusionslösung / Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- LSINF
- ATC Code
- C01CA07
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 29/04/1988
- Authorization expiration date
- 31/12/9999
- IT number
- 02.05.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DOBUTREX sol perf 250 mg/50ml flac 50 ml
- Description (DE)
- DOBUTREX Inf Lös 250 mg/50ml Durchstf 50 ml
- Market launch
- 30/09/2005
- Narcotic (BTM)
- No